Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

PIRAMAL PHARMA Gains 5%; BSE HEALTHCARE Index Up 0.2%
Tue, 15 Oct 13:40

PIRAMAL PHARMA Gains 5%; BSE HEALTHCARE Index Up 0.2%Image source: DNY59/www.istockphoto.com

PIRAMAL PHARMA share price has zoomed 5% and is presently trading at Rs 230.0.

Meanwhile, the BSE HEALTHCARE index is at 44,697.0 (up 0.2%).

Among the top gainers in the BSE HEALTHCARE index today are Jubilant Pharmova (up 6.0%) and FDC (up 4.5%).

Natco Pharma (down 2.9%) and GLAND PHARMA (down 2.6%) are among the top losers today.

Over the last one year, PIRAMAL PHARMA has moved up from Rs 98.6 to Rs 230.0, registering a gain of Rs 131.4 (up 133.3%).

On the other hand, the BSE HEALTHCARE index has moved up from 28,152.0 to 44,697.0, registering a gain of 58.8% during the last 12 months.

The top gainers among the BSE HEALTHCARE index stocks during this same period were Jubilant Pharmova (up 192.8%), Glenmark Pharma (up 131.9%) and SUVEN PHARMACEUTICALS (up 111.6%).

Dear Reader: If You Invest in Midcap Stocks, this is for You

What About the Benchmark Indices?

The BSE Sensex is at 81,756.4 (down 0.3%).

The top losers among the BSE Sensex today are Bajaj Finance (down 2.4%) and M&M (down 1.8%). The most traded stocks in the BSE Sensex are Tata Steel and Reliance Ind..

In the meantime, NSE Nifty is at 25,060.2 (down 0.3%). Bajaj Auto and Hindalco are among the top losers in NSE NIFTY.

Over the last 12 months, the BSE Sensex has moved up from 66,473.1 to 81,756.4, registering a gain of 15,283.4 points (up 23.0%).

PIRAMAL PHARMA Financial Update...

PIRAMAL PHARMA net profit grew 1.7% YoY to Rs -1,110 million for the quarter ended June 2024, compared to a loss of Rs 1,130 million a year ago. Net sales rose 11.6% to Rs 19,511 million during the period as against Rs 17,489 million in April-June 2023.

For the year ended March 2024, PIRAMAL PHARMA reported 109.6% increase in net profit to Rs 178 million compared to net loss of Rs 1,865 million during FY23. Revenue of the company grew 15.4% to Rs 81,712 million during FY24.

The current Price to earnings ratio of PIRAMAL PHARMA, based on rolling 12 month earnings, stands at -767.4.


Equitymaster requests your view! Post a comment on "PIRAMAL PHARMA Gains 5%; BSE HEALTHCARE Index Up 0.2%". Click here!